Team

Dr. Chris Moriates is the Executive Director for Costs of Care. He is also the Chief of Hospital Medicine for the VA Greater Los Angeles Healthcare System, and a Full Professor of Clinical Medicine at UCLA. He previously served as the Assistant Dean for Healthcare Value, Associate Chair for Quality, Safety, and Value, and an Associate Professor at Dell Medical School at The University of Texas at Austin. Dr. Moriates led the creation of the UCSF Cost Awareness Curriculum, the Dell Med Discovering Value-Based Health Care Interactive Learning Modules, and the U.S STARS Program. He co-authored the book Understanding Value-Based Healthcare (McGraw-Hill, 2015) and has published more than 75 peer-reviewed articles.

Ms. Wallingford is the Deputy Director for Costs of Care. She leads and supports multiple grants and subcontracts from various organizations, as well as develops partnerships with leading healthcare organizations such as The Leapfrog Group, Institute for Healthcare Improvement (IHI), and the Robert Wood Johnson Foundation. Ms. Wallingford is a practicing medical/surgical oncology nurse at a large academic medical center in Boston, Massachusetts, and has brought significant interprofessional insights to the Costs of Care team.

Arjun Gupta, MD is an Assistant Professor in the Division of Hematology, Oncology and Transplantation at the University of Minnesota. He served as the inaugural Costs of Care Fellow in 2018. He is a gastrointestinal medical oncologist, a symptom intervention trialist, and a health services researcher. His research specifically examines cancer care access and delivery, the costs of cancer care, and the hidden burdens imposed on and faced by people with cancer and their caregivers while receiving this care.

Fumiko Chino, MD is a cancer researcher and Assistant Professor in Breast Radiation Oncology at MD Anderson Cancer Center, and was a founding lead of the Affordability Working Group at Memorial Sloan Kettering. Her research is focused on patient-centered care including the financial toxicity of cancer care and survivorship, healthcare disparities, equity, and access. She is the recipient of the inaugural 2022 ASCO Excellence in Equity Award and the Chair of the 2025 ASCO Quality Care Symposium. Her work has been published in Lancet Oncology, JAMA Internal Medicine, and JAMA Oncology, and her commentary on healthcare reform and cancer care has been featured in the New England Journal of Medicine, JAMA Oncology, and The Los Angeles Times. In July 2024, she testified for the Congress HELP Committee  (Health, Education, Labor and Pensions) on the harms of medical debt. Her work has been covered by national news media outlets including the New York Times, Forbes, NPR, and NBC News. She has received research support from the NIH, the Radiation Oncology Institute, and the Chanel Foundation and has spoken across the US and internationally on equity and the costs of care. She serves as an Associate Editor for JAMA Network Open and a Special Editor for JCO Oncology Practice.

Dr. Hannah Bassett is a Clinical Assistant Professor at Stanford University School of Medicine and a pediatric hospitalist at Lucile Packard Children’s Hospital (LPCH). She is the co-director of the Packard Clinical Pathway Program and the Physician Lead for Acute Care in the Clinical Effectiveness Program at LPCH. Her institutional work focuses on decreasing unnecessary variation in clinical care, promoting high value care at the bedside, and making it easier for clinical teams to “do the right thing, for the right patient, at the right time.” Her research focuses on patient- and family-centered healthcare cost transparency and better understanding the financial impact of acute care.

Meera is a cancer care delivery research scientist and thoracic medical oncologist at Kaiser Permanente Northern California. She was the 2022-2023 Costs of Care fellow during which she conducted a study evaluating access to pharmacy assistance programs for oral anti-cancer medications. She is passionate about promoting equity and affordability in cancer care delivery. She specifically studies structural and financial barriers to clinical trial enrollment, optimal ways to screen for social and financial needs, and the impact of financial resources on clinical outcomes for patients with cancer. She plans to dedicate her career to developing and improving patient-centered models of high-value care within oncology. Meera received her undergraduate degree at the University of Pennsylvania and completed her M.D and training in Internal Medicine at Stanford University. She then completed her medical oncology fellowship at the University of California, San Francisco in 2023. She additionally holds a Masters in Public Health with a focus in health policy from the Harvard T.H Chan School of Public Health.

Christopher Petrilli is an Associate Professor in the Department of Medicine at the NYU School of Medicine. He serves as Senior Director of Revenue Cycle Operations Management for NYU Langone Health.  He has published over 30-peer reviewed papers, including one of the first and largest studies identifying COVID-19 risk factors in BMJ.

Prior to moving to NYU in 2018, he was an Assistant Professor in the Department of Internal Medicine at the University of Michigan Medical School. He was the Value Innovator for the Michigan Program for Value Enhancement and the Co-Chair of Michigan Medicine’s Laboratory Stewardship Committee. Dr. Petrilli is a Certified Healthcare Financial Professional by the Healthcare Financial Management Association. Dr. Petrilli received his Medical Degree from Georgetown University, and completed his residency training in Internal Medicine at University of Michigan where he also served as Chief Medical Resident.